| For: | Ghazanfar H, Javed N, Qasim A, Sosa F, Altaf F, Khan S, Mahasamudram J, Jyala A, Kandhi SD, Shin D, Mantri N, Sun H, Hanumanthu S, Patel H, Makker J, Balar B, Dev A, Chilimuri S. Is it necessary to stop glucagon-like peptide-1 receptor agonists prior to endoscopic procedure? A retrospective study. World J Gastroenterol 2024; 30(26): 3221-3228 [PMID: 39086638 DOI: 10.3748/wjg.v30.i26.3221] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i26/3221.htm |
| Number | Citing Articles |
| 1 |
Adriana D. Oprea, Laura J. Ostapenko, BobbieJean Sweitzer, Angela Selzer, Joan M. Irizarry-Alvarado, Maria D. Hurtado Andrade, Carlos E. Mendez, Kristen D. Kelley, Erin Stewart, Claudia R. Fernandez Robles, Ryan M. Chadha, Michael Camilleri, Ruchi Mathur, Guillermo E. Umpierrez, David L. Hepner. Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement. British Journal of Anaesthesia 2025; 135(1) doi: 10.1016/j.bja.2025.04.001
|
| 2 |
Rosita D. Frazier, William L. Hasler. Impact of GLP-1 receptor agonists on gastrointestinal function and symptoms. Expert Review of Gastroenterology & Hepatology 2025; 19(11) doi: 10.1080/17474124.2025.2579117
|
| 3 |
Sahib Singh, Saurabh Chandan, Dushyant Singh Dahiya, Ganesh Aswath, Daryl Ramai, Marcello Maida, Andrea Anderloni, Nicola Muscatiello, Antonio Facciorusso. Impact of GLP-1 Receptor Agonists in Gastrointestinal Endoscopy: An Updated Review. Journal of Clinical Medicine 2024; 13(18) doi: 10.3390/jcm13185627
|
| 4 |
Yujia Shi. The hidden advantage: colonoscopy preparation mitigates gastric content risk associated with glucagon-like peptide-1 receptor agonists. Gastrointestinal Endoscopy 2026; 103(2) doi: 10.1016/j.gie.2025.07.032
|
| 5 |
Richard Hsu, Esther Han, Sarah Swartz, Michelle Pacis. Glucagon-Like Peptide-1 Receptor Agonists in Gynecologic Surgery. Obstetrics & Gynecology 2025; 146(6) doi: 10.1097/AOG.0000000000006035
|
| 6 |
Thomas A Elimihele, Anjali M Mangrola, Oluwatobi Oshomoji, Nateshia B Wilson, Ikenna Nnamani, Bryan Ashong, Sunteasja Billings, Daniel K Getu, Sachin Kumar, Benedict Maliakkal. Confounding Factors in the Association Between Glucagon-Like Peptide-1 Receptor Agonist Use and Retained Gastric Contents in Asymptomatic Patients Undergoing Upper Gastrointestinal Endoscopy: A Retrospective Study. Cureus 2024; doi: 10.7759/cureus.69152
|
| 7 |
Trevor S. Barlowe, Lindsey N. Gouker, John B. Buse, Robert S. Sandler, Michael K. Dougherty. GLP-1 Receptor Agonists and Endoscopic Procedural Optimization: How To Minimize Risk and Improve Outcomes. Current Treatment Options in Gastroenterology 2025; 23(1) doi: 10.1007/s11938-025-00472-w
|
| 8 |
Praveen Reddy Elmati, Gowthami Sai Kogilathota Jagirdhar, Rakhtan K. Qasba, Andres Perez, Ruman K. Qasba, Yatinder Bains, Mehul Shah, Salim Surani. GLP-1 Agonists and the Risk of Pulmonary Aspiration during Elective Upper Endoscopy: A Systematic Review and Meta-analysis. The Open Respiratory Medicine Journal 2025; 19(1) doi: 10.2174/0118743064372550250603061720
|
| 9 |
Zachary I. Merhavy, Zachary Kowal, Taylor Spencer, Anna Maria Trachuk, Alexander Aldanese, Zulfiqar Ahmed, Camelia Arsene. Perioperative anesthesia management of GLP-1 receptor agonists: a systematic review of potential risks. Perioperative Medicine 2026; 15(1) doi: 10.1186/s13741-026-00662-9
|
| 10 |
Harsimran Kalsi, Raghav Bassi, Hussein Noureldine, Kobina Essilfie-Quaye, Carson Creamer, Mohammad Abuassi, Robyn Meadows, Tony S. Brar, Yaseen Perbtani. Peri-Procedural Safety of GLP-1 Receptor Agonists in Elective Endoscopy: A Multicenter Retrospective Cohort Study. Journal of Clinical Medicine 2025; 14(17) doi: 10.3390/jcm14176147
|
| 11 |
Alaa Ismail, Mohab Sherif Amer, Ahmed Tawheed. Glucagon-like peptide-1 receptor agonists: Evolution, gastrointestinal adverse effects, and future directions. World Journal of Gastrointestinal Pharmacology and Therapeutics 2025; 16(3): 107148 doi: 10.4292/wjgpt.v16.i3.107148
|
| 12 |
Ying Tan, Xian Zhang, Xiu-He Lv, Yi-Ning Sun, Jin-Lin Yang, Xue Xiao. Glucagon-like peptide-1 receptor agonists increase the risk of residual gastric content and pulmonary aspiration on upper endoscopy: A meta-analysis. Digestive and Liver Disease 2025; 57(7) doi: 10.1016/j.dld.2025.03.002
|
| 13 |
Emerson Cestari Marino, Leandra Anália Freitas Negretto, Rogério Silicani Ribeiro, Denise Momesso, Alina Coutinho Rodrigues Feitosa, Marcos Tadashi Kakitani Toyoshima, Joaquim Custódio da Silva Junior, Sérgio Vencio, Marcio Weissheimer Lauria, João Roberto de Sá, Domingos A. Malerbi, Fernando Valente, Silmara A. O. Leite, Danillo Ewerton Oliveira Amaral, Gabriel Magalhães Nunes Guimarães, Plínio da Cunha Leal, Maristela Bueno Lopes, Luiz Carlos Bastos Salles, Liana Maria Torres de Araújo Azi, Amanda Gomes Fonseca, Lorena Ibiapina M. Carvalho, Francília Faloni Coelho, Bruno Halpern, Cynthia M. Valerio, Fabio R. Trujilho, Antonio Carlos Aguiar Brandão, Ruy Lyra, Marcello Bertoluci. Perioperative screening and management of hyperglycemia: a joint position statement from the Brazilian Diabetes Society (SBD), the Brazilian Society of Anesthesiology (SBA) and the Brazilian Association for the Study of Obesity and Metabolic Syndrome (ABESO). Diabetology & Metabolic Syndrome 2026; 18(1) doi: 10.1186/s13098-025-02060-5
|
| 14 |
Akram I. Ahmad, Samita Garg, Jeffrey Jacobs, Zaid Ansari, Tasneem Jamal Al-Din, Ashraf Almomani, Sara Valencia, John Vargo, Arjun Chatterjee, Hassan Siddiki, Liang Hong, Michael A. Nicolas, Alaina Miller, Tilak Shah. Holding vs Continuing GLP-1/GIP Agonists Before Upper Endoscopy. JAMA Internal Medicine 2026; 186(5) doi: 10.1001/jamainternmed.2026.0027
|
| 15 |
Bharati Dev, Yousaf Hadi, Anam Rizvi, Christopher Cao, Brian Horwich, Nicholas A. Hoerter. Low Rates of Aborted Endoscopy Due to Gastric Food Retention in Patients on Glucagon-Like-Peptide-1 Receptor Agonists. Digestive Diseases and Sciences 2025; 70(5) doi: 10.1007/s10620-025-08915-1
|
| 16 |
Glenio B. Mizubuti, Philip M. Jones, Ion Hobai. GLP-1 Receptor Agonists and Perioperative Care: Comment. Anesthesiology 2025; 142(6) doi: 10.1097/ALN.0000000000005427
|
| 17 |
Chloe Lahoud, Malek Kreidieh, Liliane Deeb. GLP-1 Receptor Agonists in Gastrointestinal Practices: Enhancing Both Procedural and Patient-Related Outcomes. SN Comprehensive Clinical Medicine 2025; 7(1) doi: 10.1007/s42399-025-01961-w
|
| 18 |
Osama Waleed Abdallah, Ahmad Albashtawi, Sara Aljabr, Nicole Issi, Abdelkader O Rababah, Nooran Alshyyab , Shams A Shadid, Aya N Alqurneh, Ahmad Difallah Al Darawsheh, Farah M Khazneh, Nuha Najib Almaghrebi, Abdelrahman K Alsaidi, Moneer Ibrahim l., Qais Shaban, Noor Rasheed, Mina Alhashemi, Majd Kharabsheh. Peri-Procedural Fasting and Gastric Ultrasound Strategies in Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Users: A Systematic Review With Qualitative Synthesis. Cureus 2026; doi: 10.7759/cureus.108216
|
| 19 |
Ronald M. Goldenberg, Jeremy D. Gilbert, Robyn L. Houlden, Tayyab S. Khan, Sapna Makhija, C. David Mazer, Jill Trinacty, Subodh Verma. Perioperative and periprocedural management of GLP-1 receptor-based agonists and SGLT2 inhibitors: narrative review and the STOP-GAP and STOP DKA-2 algorithms. Current Medical Research and Opinion 2025; 41(3) doi: 10.1080/03007995.2025.2458538
|
| 20 |
V. V. Salukhov, A. V. Shchegolev, E. V. Kryukov, P. V. Surzhikov, E. V. Apostolidi, Ya. E. Prochik. Preoperative management algorithm for endoscopic or surgical interventions in patients receiving incretin mimetics. Meditsinskiy sovet = Medical Council 2026; doi: 10.21518/ms2026-161
|